Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles OncoImmunology Year : 2018

Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside

Domains

Cancer

Dates and versions

inserm-01596068 , version 1 (27-09-2017)

Identifiers

Cite

S. Faraj, M. Bahri, S. Fougeray, A. El Roz, J. Fleurence, et al.. Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside. OncoImmunology, 2018, 7 (1), ⟨10.1080/2162402X.2017.1373232⟩. ⟨inserm-01596068⟩
127 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More